NCT03784573

Brief Summary

Compare the effect of a single exposure to a therapy dog and handler within the pediatric emergency department patient with anxiety by measuring the change in patient perception of anxiety before and after dog exposure using the FACES scale. We will also measure galvanic skin response (resistance to electrical current).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 24, 2018

Completed
14 days until next milestone

Study Start

First participant enrolled

January 7, 2019

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

5.5 years

First QC Date

December 17, 2018

Last Update Submit

July 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in anxiety level of subject

    Change in anxiety level of subject with the use of the FACES scale

    45 minutes

Secondary Outcomes (6)

  • Perception of anxiety level from physician

    60 minutes

  • Perception of pain level from physician

    60 minutes

  • Perception of anxiety level from parent(s)

    60 minutes

  • Perception of pain level from parent(s)

    60 minutes

  • Meds

    4 hours

  • +1 more secondary outcomes

Study Arms (2)

Dog + handler

ACTIVE COMPARATOR
Behavioral: Dog + handler

No dog

PLACEBO COMPARATOR
Behavioral: No dog

Interventions

Dog + handlerBEHAVIORAL

Dog + handler

Dog + handler
No dogBEHAVIORAL

No dog

No dog

Eligibility Criteria

Age4 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • years old;
  • Physician or nurse with primary care responsibilities believes that the patients has a moderate to high level of anxiety

You may not qualify if:

  • \- violent behavior and any reported prior fear or adverse reaction to dogs in the dog intervention group.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IU Health Riley Children's Hospital

Indianapolis, Indiana, 46202, United States

Location

Related Publications (1)

  • Kelker HP, Siddiqui HK, Beck AM, Kline JA. Therapy Dogs for Anxiety in Children in the Emergency Department: A Randomized Clinical Trial. JAMA Netw Open. 2025 Mar 3;8(3):e250636. doi: 10.1001/jamanetworkopen.2025.0636.

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Subjects will be randomized per dog and handler availability, but subjects that are excluded due to an aversion or dogs or per the Child Life staff member, can be in the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 17, 2018

First Posted

December 24, 2018

Study Start

January 7, 2019

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

July 17, 2024

Record last verified: 2024-07

Locations